The market for real estate listings has rebounded sharply from pandemic-related weakness and REA Group appears well placed for volume growth in FY21.
Has demand for ventilators stemming from the pandemic run its course? The main issue for ResMed in the near term is whether a reduction in ventilator sales will be countered by a recovery in its sleep business.
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Despite heightened volatility, Pinnacle Investment Management appears well on the way to derive material success from its new ventures.
The ASX200 rose a measly 0.5% in July led by materials, technology and consumer staples; the August reporting season may find companies hesitant to provide guidance amid an uncertain outlook
Incitec Pivot has updated on the key components driving the business, amid challenging conditions stemming from low prices and the pandemic
Structural change in the wagering industry has met the coronavirus pandemic head on, resulting in heightened risks for Tabcorp.
Despite the challenges posed in FY21 Macquarie Group remains in a strong position to take advantage of any opportunities which present.
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.
The dividend outlook for banks has weighed heavily on valuations since the onset of the pandemic and the resultant economic slump. Has the prudential regulator, APRA, set minds at rest?